Comparison of the beta blocker bucindolol in younger versus older patients with heart failure

被引：13

作者：

Aranda, JM

Krause-Steinrauf, HJ

Greenberg, BH

Heng, MK

Kosolcharoen, PK

Renlund, DG

Thaneemit-Chen, S

White, M

Cintron, GB

机构：

[1] Univ Florida, Coll Med, Gainesville, FL 32610 USA

[2] Gainesville Vet Adm Med Ctr, Gainesville, FL USA

[3] NHLBI, Bethesda, MD 20892 USA

[4] Univ Calif San Diego, San Diego, CA 92103 USA

[5] Sepulveda Vet Adm Med Ctr, Sepulveda, CA USA

[6] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA

[7] Latter Day St Hosp, Salt Lake City, UT 84143 USA

[8] Dept Vet Affairs Palo Alto Hlth Care Syst, CSPCC, Palo Alto, CA USA

[9] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada

[10] Tampa Vet Adm Med Ctr, Tampa, FL USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2002年 / 89卷 / 11期

关键词：

D O I：

10.1016/S0002-9149(02)02339-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The elderly population in the Beta-Blocker Evaluation of Survival Trial is a sicker cohort of patients characterized by increased duration of heart failure, more coronary artery disease, and higher mortality. Compared with younger patients, older patients with heart failure safely tolerate the beta blocker bucindolol with similar physiologic effects; advanced age should not be the sole reason for avoiding beta blockers in elderly patients with heart failure.

引用

页码：1322 / +

页数：6

共 11 条

[1] HYPERTENSION IN THE ELDERLY [J].